{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:10:20Z","timestamp":1792285820701,"version":"4.4.0"},"reference-count":98,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.2217\/imt-2020-0184","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T08:21:08Z","timestamp":1618474868000},"page":"693-721","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Three Decades of Clinical Trials on Immunotherapy for Human Leishmaniases: a Systematic Review and Meta-Analysis"],"prefix":"10.1080","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7702-2812","authenticated-orcid":false,"given":"Camila Alves","family":"Mota","sequence":"first","affiliation":[{"name":"Graduate Program in Health Sciences, State University of Maring\u00e1, Maring\u00e1, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9055-4634","authenticated-orcid":false,"given":"Jully","family":"Oyama","sequence":"additional","affiliation":[{"name":"Graduate Program in Bioscience & Physiopathology, State University of Maring\u00e1, Maring\u00e1, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9125-6818","authenticated-orcid":false,"given":"Mariana de","family":"Souza Terron Monich","sequence":"additional","affiliation":[{"name":"Graduate Program in Health Sciences, State University of Maring\u00e1, Maring\u00e1, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5051-5369","authenticated-orcid":false,"given":"Aline \u00c1vila","family":"Brustolin","sequence":"additional","affiliation":[{"name":"Graduate Program in Health Sciences, State University of Maring\u00e1, Maring\u00e1, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4863-0071","authenticated-orcid":false,"given":"Jo\u00e3o V\u00edtor","family":"Perez de Souza","sequence":"additional","affiliation":[{"name":"Graduate Program in Bioscience & Physiopathology, State University of Maring\u00e1, Maring\u00e1, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7456-7689","authenticated-orcid":false,"given":"Let\u00edcia Sayuri","family":"Murase","sequence":"additional","affiliation":[{"name":"Graduate Program in Health Sciences, State University of Maring\u00e1, Maring\u00e1, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-2284","authenticated-orcid":false,"given":"Luciana Dias","family":"Ghiraldi Lopes","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, Department of Clinical Analysis & Biomedicine, State University of Maring\u00e1, Maring\u00e1, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0227-131X","authenticated-orcid":false,"given":"Thais da","family":"Silva Santos","sequence":"additional","affiliation":[{"name":"Graduate Program in Bioscience & Physiopathology, State University of Maring\u00e1, Maring\u00e1, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7719-5350","authenticated-orcid":false,"given":"Jorge Juarez","family":"Vieira Teixeira","sequence":"additional","affiliation":[{"name":"Laboratory of Leishmaniases, Department of Clinical Analysis & Biomedicine, State University of Maring\u00e1, Maring\u00e1, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5527-9358","authenticated-orcid":false,"given":"Tha\u00eds Gomes","family":"Verzignassi Silveira","sequence":"additional","affiliation":[{"name":"Laboratory of Leishmaniases, Department of Clinical Analysis & Biomedicine, State University of Maring\u00e1, Maring\u00e1, Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"e_1_3_5_3_1","unstructured":"World Health Organization\n. Leishmaniasis fact sheet. (2020). www.who.int\/en\/news-room\/fact-sheets\/detail\/leishmaniasis"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1748"},{"issue":"3","key":"e_1_3_5_5_1","first-page":"22","article-title":"Control of leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases","volume":"949","author":"World Health Organization","year":"2010","unstructured":"World Health Organization . Control of leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. WHO Tech. Rep. Ser.949(3), 22\u201326 (March 2010). https:\/\/apps.who.int\/iris\/handle\/10665\/44412","journal-title":"WHO Tech. Rep. Ser."},{"issue":"196","key":"e_1_3_5_6_1","first-page":"1","article-title":"Report of the post Kala-Azar dermal leishmaniasis (PKDL) consortium meeting, New Delhi, India, 27\u201329 June 2012","volume":"6","author":"Desjeux P","year":"2013","unstructured":"Desjeux P , GhoshRS , DhalariaP , Strub-WourgaftN , ZijlstraEE. Report of the post Kala-Azar dermal leishmaniasis (PKDL) consortium meeting, New Delhi, India, 27\u201329 June 2012. Parasites and Vectors.6(196), 1\u201321 (2013).","journal-title":"Parasites and Vectors."},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04558.x"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70209-8"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035671"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.12.016"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-5-113"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/506624"},{"key":"e_1_3_5_13_1","unstructured":"Centers for Disease Control and Prevention C\n. Parasites \u2013 Leishmaniasis. (2020). www.cdc.gov\/parasites\/leishmaniasis\/health_professionals\/index.html"},{"key":"e_1_3_5_14_1","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-l\u00f3pez M SotoM IborraS SanchoD. Leishmania hijacks myeloid cells for immune escape. 9(5) 1\u201316 (2018).","DOI":"10.3389\/fmicb.2018.00883"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-407679-2.00005-3"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463200702000302"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/203818"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/79734"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00670"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.6.1797"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.4.741"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.148.4.1182"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.72"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132710"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01437"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.4.2205"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13173"},{"key":"e_1_3_5_28_1","volume-title":"Cellular and Molecular Immunology (Volume 8).","author":"Abbas AK","year":"2014","unstructured":"Abbas AK , LichtmanAH , PillaiS. Cellular and Molecular Immunology (Volume 8).Saunders, PA, USA (2014)."},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.2.1141"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01779"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.1015"},{"key":"e_1_3_5_32_1","first-page":"1","article-title":"Costs of medicines in current use for the treatment of leishmaniasis","volume":"949","author":"World Health Organization","year":"2010","unstructured":"World Health Organization . Costs of medicines in current use for the treatment of leishmaniasis. Tech. Rep. Ser.949, 1\u20132 (2010).","journal-title":"Tech. Rep. Ser."},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules14072317"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006052"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01492"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01336.x"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/160.1.104"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0037-86822006000100003"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02761994000300034"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1086\/507708"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2014.945415"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3963561"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1159\/000503684"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226320"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.14.43"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1086\/315082"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1086\/424848"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2005.73.79"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1993.13.39"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01728914"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.3.659"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.4.992"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.6.1627"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1086\/516526"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90116-4"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(03)90093-9"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3024.1989.tb00660.x"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3024.2000.00278.x"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2007.08.006"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762001000100010"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2009.07.012"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962013000100003"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.08.092"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.07.063"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3RU0316-144R"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00665.x"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1413-86702001000400008"},{"issue":"3","key":"e_1_3_5_70_1","first-page":"197","article-title":"Liposomal amphotericin B and rHuGM-CSF for treatment of visceral leishmaniasis in AIDS","volume":"12","author":"Mastroianni A","year":"2004","unstructured":"Mastroianni A . Liposomal amphotericin B and rHuGM-CSF for treatment of visceral leishmaniasis in AIDS. Infez. Med.12(3), 197\u2013204 (2004).","journal-title":"Infez. Med."},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.01.099"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-2218"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2014.15"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix525"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-020-0325-9"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0337-y"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2009.81.378"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijpvm.IJPVM_116_18"},{"key":"e_1_3_5_79_1","first-page":"2","article-title":"Post-kala-azar dermal leishmaniasis: a manual for case management and control","author":"World Health Organization","year":"2012","unstructured":"World Health Organization . Post-kala-azar dermal leishmaniasis: a manual for case management and control. Rep. a WHO Consulative Meet. Kolkata, India., 2\u20133 (July 2012). www.who.int\/neglected_diseases\/resources\/9789241505215\/en\/","journal-title":"Rep. a WHO Consulative Meet. Kolkata, India."},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1179\/146532806X152890"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.03.058"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.8.4215-4225.2002"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000238"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.02.096"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.045"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.089"},{"key":"e_1_3_5_87_1","unstructured":"ClinicalTrials.gov\n. Study to evaluate the Leish-111F + MPL-SE vaccine in the treatment of cutaneous leishmaniasis. (2005). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00111553"},{"key":"e_1_3_5_88_1","unstructured":"ClinicalTrials.gov\n. Study to evaluate the Leish-111F + MPL-SE vaccine in the treatment of mucosal leishmaniasis. (2005). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00111514"},{"key":"e_1_3_5_89_1","unstructured":"ClinicalTrials.gov\n. A study of the efficacy and safety of the LEISH-F2 + MPL-SE vaccine for treatment of cutaneous leishmaniasis. (2009). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01011309"},{"key":"e_1_3_5_90_1","unstructured":"ClinicalTrials.gov\n. Safety and immunogenicity of the LEISH-F2 + MPL-SE vaccine with SSG for patients with PKDL (2009). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00982774"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005527"},{"key":"e_1_3_5_92_1","unstructured":"ClinicalTrials.gov\n. A study of a new Leishmania vaccine candidate ChAd63-KH. (2016). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02894008"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13235"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1086\/324161"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1086\/518172"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2003.01955.x"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1086\/429238"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000491"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.12.1575"},{"issue":"4","key":"e_1_3_5_100_1","first-page":"238","article-title":"Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy","volume":"14","author":"Meymandi SS","year":"2011","unstructured":"Meymandi SS , JavadiA , DabiriS , MeymandiMS , NadjiM. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy. Arch. Iran. Med.14(4), 238\u2013243 (2011).","journal-title":"Arch. Iran. Med."}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2020-0184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T20:47:37Z","timestamp":1715978857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2020-0184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":98,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.2217\/imt-2020-0184"],"URL":"https:\/\/doi.org\/10.2217\/imt-2020-0184","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-06-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}